Skip to main content

Market Overview

Metiscan's Subsidiary FirstView EHR Launches New Outbound Marketing Strategy

Share:

DALLAS, TX--(Marketwire - August 17, 2009) - Metiscan, Inc. (PINKSHEETS: MTIZ), a holding
company focused on growing its organization by making key acquisitions and
developing companies and emerging technologies, announced today that its
wholly owned Subsidiary, FirstView EHR, Inc. (FirstView) has launched a new
outbound marketing strategy focused on expanding FirstView's footprint
within the diagnostic imaging market.

FirstView provides end-to-end IT services for diagnostic imaging facilities
including web based electronic healthcare records (EHR), workflow
efficiency, PACS administration, long-term archiving, professional IT
services and strategic HL7 interoperability consulting. FirstView's CEO,
Iain Shigeoka, Ph.D., holds the Control Specialist Certification for Health
Language Seven (HL7) Version 2 standards.

FirstView launched its new outbound marketing strategy to better position
the Company to capitalize on a portion of the recently passed American
Recovery and Reinvestment Act of 2009, better known as the "Economic
Stimulus Bill." The final package of $787 billion was signed into law by
President Barack Obama on February 17, 2009. The plan allocates $20B to
encourage the adoption of health information technology including payments
to physicians who can demonstrate they are using electronic heath records
(EHR) systems. FirstView currently provides such healthcare IT systems and
solutions to diagnostic imaging facilities.

"We have added additional resources to our team to actively call upon
outpatient imaging facilities within the United States that will
financially benefit from our end-to-end EHR service offering," commented
Jacob Cohen, EVP. "Our goal is to continue to increase our footprint
within this market while evaluating solutions that fit within our core
competencies allowing us to offer similar EHR services to the Physician
Office market. By doing so, it will enable FirstView to capitalize on a
larger portion of the $20B American Recovery and Reinvestment Act of 2009.
Similar to GE, through its related companies GE Healthcare and GE Capital,
we are evaluating creating a program whereby we will provide certified EHR
systems to diagnostic imaging centers and physicians offices with deferred
payment plans."

To learn more about the American Recovery and Reinvestment Act of 2009
visit Digimed Healthcare IT (http://www.digimedhit.com/stimulus.asp).

About Metiscan, Inc.

Metiscan, Inc. is a holding company focused on growing its organization by
making key acquisitions and developing companies and emerging technologies.
Previously, Metiscan had been focused on healthcare related businesses and
is currently pursuing acquisitions and opportunities related to healthcare
and non-healthcare mobile products and services.

Metiscan operates FirstView EHR, Inc., a wholly owned subsidiary, that
provides
end-to-end IT services for diagnostic imaging facilities including web
based electronic healthcare records (EHR), workflow efficiency, PACS
administration, long-term archiving, professional IT services and strategic
consulting. Metiscan operates Schuylkill Open MRI, Inc., a majority owned
subsidiary that is an independent diagnostic testing facility (IDTF)
providing Magnetic Resonance Imaging (MRI) services. Metiscan also operates
Taptopia, Inc., a wholly owned subsidiary that provides design and
development services for Smartphone platforms. Metiscan also operates
Shoreline Employment Services, Inc., a wholly owned subsidiary that
provides employment services and benefits to all of Metiscan's subsidiaries
and intends to provide such services to third parties in the future.

Safe Harbor Statement: Certain of the statements made in this press release
constitute forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933 and Section 27E of the Securities Act of 1934.
Such forward-looking statements involve known and unknown risks,
uncertainties and other unknown factors that could cause Metiscan's actual
results to be materially different from the historical results or from any
future results expressed or implied by such forward-looking statements.
Statements contained in this release that are not historical facts may be
deemed to be forward-looking statements. In addition to statements that
explicitly describe such risks and uncertainties, readers are urged to
consider statements labeled with the terms "believes," "belief," "intends,"
"anticipates" or "plans" to be uncertain and forward-looking. The Company
does not intend to update any of the forward-looking statements after the
date of this release to conform these statements to actual results or to
changes in its expectations, except as may be required by law.

 

Related Articles (EVP + D)

View Comments and Join the Discussion!